Molecular analysis of inherited cardiomyopathy using next generation semiconductor sequencing technologies
- PMID: 30165862
- PMCID: PMC6117967
- DOI: 10.1186/s12967-018-1605-5
Molecular analysis of inherited cardiomyopathy using next generation semiconductor sequencing technologies
Abstract
Background: Cardiomyopathies are the most common clinical and genetic heterogeneity cardiac diseases, and genetic contribution in particular plays a major role in patients with primary cardiomyopathies. The aim of this study is to investigate cases of inherited cardiomyopathy (IC) for potential disease-causing mutations in 64 genes reported to be associated with IC.
Methods: A total of 110 independent cases or families diagnosed with various primary cardiomyopathies, including hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, left ventricular non-compaction, and undefined cardiomyopathy, were collected after informed consent. A custom designed panel, including 64 genes, was screened using next generation sequencing on the Ion Torrent PGM platform. The best candidate disease-causing variants were verified by Sanger sequencing.
Results: A total of 78 variants in 73 patients were identified. After excluding the variants predicted to be benign and VUS, 26 pathogenic or likely pathogenic variants were verified in 26 probands (23.6%), including a homozygous variant in the SLC25A4 gene. Of these variants, 15 have been reported in the Human Gene Mutation Database or ClinVar database, while 11 are novel. The majority of variants were observed in the MYH7 (8/26) and MYBPC3 (6/26) gene. Titin (TTN) truncating mutations account for 13% in our dilated cardiomyopathy cases (3/23).
Conclusions: This study provides an overview of the genetic aberrations in this cohort of Chinese IC patients and demonstrates the power of next generation sequencing in IC. Genetic results can provide precise clinical diagnosis and guidance regarding medical care for some individuals.
Keywords: Inherited cardiomyopathy; Mutation; Next generation sequencing; TTN.
Figures

Similar articles
-
Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.J Am Heart Assoc. 2015 Jul 10;4(7):e001879. doi: 10.1161/JAHA.115.001879. J Am Heart Assoc. 2015. PMID: 26163040 Free PMC article.
-
[Recommendations for gene assays for cardiomyopathy in children].Zhonghua Er Ke Za Zhi. 2013 Aug;51(8):595-7. Zhonghua Er Ke Za Zhi. 2013. PMID: 24225290 Chinese. No abstract available.
-
Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling.Sci Rep. 2018 Jan 31;8(1):1998. doi: 10.1038/s41598-018-20114-9. Sci Rep. 2018. PMID: 29386531 Free PMC article.
-
[Mutations genes in primarly cardiomyopathies].Med Arh. 2007;61(2 Suppl 1):18-22. Med Arh. 2007. PMID: 21553441 Review. Bosnian.
-
Molecular mechanisms in cardiomyopathy.Clin Sci (Lond). 2017 Jul 1;131(13):1375-1392. doi: 10.1042/CS20160170. Clin Sci (Lond). 2017. PMID: 28645928 Review.
Cited by
-
An assessment of the role of vinculin loss of function variants in inherited cardiomyopathy.Hum Mutat. 2020 Sep;41(9):1577-1587. doi: 10.1002/humu.24061. Epub 2020 Jun 24. Hum Mutat. 2020. PMID: 32516855 Free PMC article.
-
Genetic analysis using targeted next-generation sequencing of sporadic Chinese patients with idiopathic dilated cardiomyopathy.J Transl Med. 2021 May 3;19(1):189. doi: 10.1186/s12967-021-02832-3. J Transl Med. 2021. PMID: 33941202 Free PMC article.
-
Molecular Diagnosis of Primary Cardiomyopathy in 231 Unrelated Pediatric Cases by Panel-Based Next-Generation Sequencing: A Major Focus on Five Carriers of Biallelic TNNI3 Pathogenic Variants.Mol Diagn Ther. 2022 Sep;26(5):551-560. doi: 10.1007/s40291-022-00604-3. Epub 2022 Jul 15. Mol Diagn Ther. 2022. PMID: 35838873
-
Exploring TTN variants as genetic insights into cardiomyopathy pathogenesis and potential emerging clues to molecular mechanisms in cardiomyopathies.Sci Rep. 2024 Mar 4;14(1):5313. doi: 10.1038/s41598-024-56154-7. Sci Rep. 2024. PMID: 38438525 Free PMC article. Review.
-
The Hidden Fragility in the Heart of the Athletes: A Review of Genetic Biomarkers.Int J Mol Sci. 2020 Sep 12;21(18):6682. doi: 10.3390/ijms21186682. Int J Mol Sci. 2020. PMID: 32932687 Free PMC article. Review.
References
-
- Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807–1816. doi: 10.1161/CIRCULATIONAHA.106.174287. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical